MeiraGTx

About MeiraGTx

MeiraGTx Holdings plc is a clinical-stage gene therapy company focused on developing innovative treatments for serious diseases, including ocular and neurodegenerative disorders. The company offers a broad pipeline of clinical, preclinical, and research programs, as well as gene therapy manufacturing and transformative gene regulation technologies such as riboswitch platforms for precise control of gene expression. MeiraGTx aims to deliver potentially curative genetic medicines for both rare and prevalent diseases, serving patients primarily in the United States.